Sanzyme Biologics
Jagan Mohan Reddy Veluri is an accomplished biochemist with extensive experience in the biopharmaceutical and enzyme development sectors. Currently serving as Deputy General Manager at Sanzyme Biologics since February 2020, Jagan Mohan Reddy leads the development of biopharmaceutical products, including L-Asparaginase and peptide products like Teriparatide and Semaglutide. Previously, Jagan Mohan Reddy held the position of Head of Department at Therazymes Pvt Ltd, focusing on enzyme development for biocatalysis. Experience at Dr. Reddy's Laboratories as a Principal Scientist and roles at Aurobindo Pharma and Unimark Remedies Ltd have strengthened Jagan Mohan Reddy's expertise in fermentation technology and biotransformation. Educational qualifications include a PhD in Biochemistry from Doctor Ram Manohar Lohia Awadh University and the Central Drug Research Institute, along with a Bachelor of Science degree in Biochemistry, Microbiology, and Food & Applied Nutrition.
This person is not in any teams
This person is not in any offices
Sanzyme Biologics
1 followers
Sanzyme Biologics is a biotechnology company specializing in the fermentation. It produces, markets, and sells proprietary probiotic strains, its flagship strain being SNZ 1969 Bacillus Coagulans (used in Sporlac). It’s aquaculture division (Kenko) directly markets its solutions to export based aquaculture farmers across India. The poultry division (Sanco) works with established market players to develop probiotics for feed / feed additive companies. Sanzyme Biologics is a sister company to Sanzyme Pvt Ltd (https://www.linkedin.com/company/2957632/)